The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Docetaxel
Docetaxel · DOCETAXEL 160 mg/8mL · Injection, Solution · Intravenous · Dr. Reddy's Laboratories Inc.
NDC 43598-0389-57 · 8 mL in 1 VIAL, GLASS · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$170.00
Reported to Texas DSHS · 2022 annual filing · Dr. Reddy's Laboratories, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $480.15 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA204193
- TE code
- AP
- Approval date
- Nov 5, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedMar 6, 2019Dr. Reddy's Laboratories, Inc. — Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Manufacturers of Docetaxel (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | DOCETAXEL 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Dr. Reddy's Laboratories Inc. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Dr. Reddy's Laboratories Inc. | DOCETAXEL 80 mg/4mL | Jul 15, 2026 | Sep 3, 2026 |
| Hospira, Inc. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Zhuhai Beihai Biotech Co., Ltd. | DOCETAXEL ANHYDROUS 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Zydus Pharmaceuticals USA Inc. | DOCETAXEL ANHYDROUS 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Avyxa Pharma, LLC | DOCETAXEL 20 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Avyxa Pharma, LLC | DOCETAXEL 80 mg/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Avyxa Pharma, LLC | DOCETAXEL 160 mg/16mL | Jul 15, 2026 | Sep 2, 2026 |
| Chongqing Sintaho Pharmaceutical Co., Ltd. | DOCETAXEL 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | DOCETAXEL 160 mg/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc. | DOCETAXEL 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | DOCETAXEL ANHYDROUS 160 mg/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | DOCETAXEL ANHYDROUS 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | DOCETAXEL ANHYDROUS 80 mg/4mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | DOCETAXEL ANHYDROUS 10 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Docetaxel — NDC 43598-0389-57," retrieved September 3, 2026, https://drugdashboards.com/drug/43598038957.
Free to cite with attribution — see how the data is put together.